These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33475833)

  • 1. Clinical impact of preoperative tumour contact with superior mesenteric-portal vein in patients with resectable pancreatic head cancer.
    Ausania F; Sanchez-Cabus S; Senra Del Rio P; Borin A; Ayuso JR; Bodenlle P; Espinoza S; Cuatrecasas M; Conill C; Saurí T; Ferrer J; Fuster J; García-Valdecasas JC; Melendez R; Fondevila C
    Langenbecks Arch Surg; 2021 Aug; 406(5):1443-1452. PubMed ID: 33475833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes following en bloc resection for pancreatic ductal adenocarcinoma of the head with portomesenteric venous invasion.
    Han S; Choi DW; Choi SH; Heo JS; Han IW; You YH
    Asian J Surg; 2021 Jan; 44(1):313-320. PubMed ID: 32972828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic role of the length of tumour-vein contact at the portal-superior mesenteric vein in patients having surgery for pancreatic cancer.
    Imamura T; Yamamoto Y; Sugiura T; Okamura Y; Ito T; Ashida R; Ohgi K; Todaka A; Fukutomi A; Aramaki T; Uesaka K
    Br J Surg; 2019 Nov; 106(12):1649-1656. PubMed ID: 31626342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of portomesenteric vein invasion and prognostic factors in pancreas head adenocarcinoma.
    Jeong J; Choi DW; Choi SH; Heo JS; Jang KT
    ANZ J Surg; 2015 Apr; 85(4):264-9. PubMed ID: 24641800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Portal or superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head carcinoma.
    Murakami Y; Satoi S; Motoi F; Sho M; Kawai M; Matsumoto I; Honda G;
    Br J Surg; 2015 Jun; 102(7):837-46. PubMed ID: 25877050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction and clinical implications of portal vein/superior mesenteric vein invasion in patients with resected pancreatic head cancer: the significance of preoperative CT parameters.
    Kim M; Kang TW; Cha DI; Kim YK; Kim SH; Jang KT; Han IW; Sohn I
    Clin Radiol; 2018 Jun; 73(6):564-573. PubMed ID: 29519500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic adenocarcinoma: A simple CT score for predicting margin-positive resection in patients with resectable disease.
    Cassinotto C; Dohan A; Zogopoulos G; Chiche L; Laurent C; Sa-Cunha A; Cuggia A; Reinhold C; Gallix B
    Eur J Radiol; 2017 Oct; 95():33-38. PubMed ID: 28987689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Portal Vein Involvement from Pancreatic Cancer on Metastatic Pattern After Surgical Resection.
    Mierke F; Hempel S; Distler M; Aust DE; Saeger HD; Weitz J; Welsch T
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):730-736. PubMed ID: 27554501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical Outcomes of Pancreatectomy with Resection of the Portal Vein and/or Superior Mesenteric Vein and Jejunal Vein for Pancreatic Head Cancer: A Multicenter Study.
    Nagakawa Y; Jang JY; Kawai M; Kim SC; Inoue Y; Matsuyama R; Heo JS; Honda M; Sugiura T; Ohtsuka M; Mizuno S; Kwon W; Uemura K; Han HS; Sugimoto M; Okano K; Nakamura M; Wada K; Kumamoto Y; Osakae H; Tsuchida A; Yoon YS; Park JS; Yamaue H; Endo I
    Ann Surg; 2023 May; 277(5):e1081-e1088. PubMed ID: 34913900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable and borderline resectable pancreatic cancer.
    Tran Cao HS; Balachandran A; Wang H; Nogueras-González GM; Bailey CE; Lee JE; Pisters PW; Evans DB; Varadhachary G; Crane CH; Aloia TA; Vauthey JN; Fleming JB; Katz MH
    J Gastrointest Surg; 2014 Feb; 18(2):269-78; discussion 278. PubMed ID: 24129826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of portal-superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head cancer.
    Han SS; Park SJ; Kim SH; Cho SY; Kim YK; Kim TH; Lee SA; Woo SM; Lee WJ; Hong EK
    Pancreas; 2012 Jan; 41(1):102-6. PubMed ID: 21775914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reassessment of the clinical significance of portal-superior mesenteric vein invasion in borderline resectable pancreatic cancer.
    Hoshimoto S; Hishinuma S; Shirakawa H; Tomikawa M; Ozawa I; Wakamatsu S; Hoshi S; Hoshi N; Hirabayashi K; Ogata Y
    Eur J Surg Oncol; 2017 Jun; 43(6):1068-1075. PubMed ID: 28427822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National Comprehensive Cancer Network Resectability Status for Pancreatic Carcinoma Predicts Overall Survival.
    Murakami Y; Satoi S; Sho M; Motoi F; Matsumoto I; Kawai M; Honda G; Uemura K; Yanagimoto H; Shinzeki M; Kurata M; Kinoshita S; Yamaue H; Unno M
    World J Surg; 2015 Sep; 39(9):2306-14. PubMed ID: 26013206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Techniques and results of portal vein/superior mesenteric vein reconstruction using femoral and saphenous vein during pancreaticoduodenectomy.
    Lee DY; Mitchell EL; Jones MA; Landry GJ; Liem TK; Sheppard BC; Billingsley KG; Moneta GL
    J Vasc Surg; 2010 Mar; 51(3):662-6. PubMed ID: 20080375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiographic portal or superior mesenteric vein invasion is an independent prognostic factor in non-metastatic pancreatic ductal adenocarcinoma: A missing block of clinical T staging?
    Kang H; Kim SS; Sung MJ; Jo JH; Lee HS; Chung MJ; Park JY; Park SW; Song SY; Park MS; Bang S
    Pancreatology; 2020 Jul; 20(5):952-959. PubMed ID: 32561070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefit of portal or superior mesenteric vein resection with adjuvant chemotherapy for patients with pancreatic head carcinoma.
    Murakami Y; Uemura K; Sudo T; Hashimoto Y; Nakashima A; Kondo N; Nakagawa N; Sueda T
    J Surg Oncol; 2013 Mar; 107(4):414-21. PubMed ID: 22886567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and treatment of pancreatic head cancer followed by mesenteric-portal vein invasion].
    Kriger AG; Karmazanovsky GG; Smirnov AV; Kharazov AF; Gorin DS; Raevskaya MB; Galkin GV; Revishvili AS
    Khirurgiia (Mosk); 2018; (12):21-29. PubMed ID: 30560841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should the portal vein be routinely resected during pancreaticoduodenectomy for adenocarcinoma?
    Turrini O; Ewald J; Barbier L; Mokart D; Blache JL; Delpero JR
    Ann Surg; 2013 Apr; 257(4):726-30. PubMed ID: 22968078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of benefits of portal-superior mesenteric vein resection in pancreatic resection for ductal adenocarcinoma.
    Giovinazzo F; Turri G; Katz MH; Heaton N; Ahmed I
    Br J Surg; 2016 Feb; 103(3):179-91. PubMed ID: 26663252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of resecting the portal vein only when necessary during pancreatoduodenectomy for pancreatic cancer.
    Kishi Y; Nara S; Esaki M; Hiraoka N; Shimada K
    BJS Open; 2019 Jun; 3(3):327-335. PubMed ID: 31183449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.